News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Coffee may protect against liver disease, including cancer
9 hours ago
byAudrey Abella
A recent study has shown an association between higher coffee intake and lower risks of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality.
Coffee may protect against liver disease, including cancer
9 hours ago
Dual glucagon/GLP-1 RA survodutide shows broad benefits in phase III obesity & MASLD trials
19 hours ago
Survodutide, a glucagon receptor–glucagon-like peptide-1 (GLP-1) receptor dual agonist, significantly reduces body weight and liver/visceral fat in individuals with obesity as well as those with obesity and at-risk metabolic dysfunction–associated steatotic liver disease (MASLD) in the phase III SYNCHRONIZE-1 and SYNCHRONIZE-MASLD trials. The data, presented at ADA 2026, also demonstrate improvements in cardiometabolic parameters indicating broad benefits associated with survodutide treatment.







